BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30385730)

  • 1. Transcriptomic heterogeneity in multifocal prostate cancer.
    Salami SS; Hovelson DH; Kaplan JB; Mathieu R; Udager AM; Curci NE; Lee M; Plouffe KR; de la Vega LL; Susani M; Rioux-Leclercq N; Spratt DE; Morgan TM; Davenport MS; Chinnaiyan AM; Cyrta J; Rubin MA; Shariat SF; Tomlins SA; Palapattu GS
    JCI Insight; 2018 Nov; 3(21):. PubMed ID: 30385730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatial transcriptomic analysis of virtual prostate biopsy reveals confounding effect of tissue heterogeneity on genomic signatures.
    Figiel S; Yin W; Doultsinos D; Erickson A; Poulose N; Singh R; Magnussen A; Anbarasan T; Teague R; He M; Lundeberg J; Loda M; Verrill C; Colling R; Gill PS; Bryant RJ; Hamdy FC; Woodcock DJ; Mills IG; Cussenot O; Lamb AD
    Mol Cancer; 2023 Oct; 22(1):162. PubMed ID: 37789377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic testing for localized prostate cancer: where do we go from here?
    Loeb S; Ross AE
    Curr Opin Urol; 2017 Sep; 27(5):495-499. PubMed ID: 28661898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is cancer? A focus on Grade Group 1 prostate cancer.
    Talwar R; Akinsola O; Penson DF
    BJU Int; 2024 Apr; 133(4):360-364. PubMed ID: 38229478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization Classification.
    Netto GJ; Amin MB; Compérat EM; Gill AJ; Hartmann A; Moch H; Menon S; Raspollini MR; Rubin MA; Srigley JR; Hoon Tan P; Tickoo SK; Tsuzuki T; Turajlic S; Cree I; Berney DM
    Eur Urol; 2023 Apr; 83(4):301-303. PubMed ID: 36202687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-cell RNA sequencing comparison of the human metastatic prostate spine tumor microenvironment.
    Nguyen AD; Haines C; Price MJ; Dalton TE; Baëta CD; Hockenberry HA; Goodwin CR
    STAR Protoc; 2024 Mar; 5(1):102805. PubMed ID: 38341849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health Economic Impact and Prospective Clinical Utility of Oncotype DX® Genomic Prostate Score.
    Albala D; Kemeter MJ; Febbo PG; Lu R; John V; Stoy D; Denes B; McCall M; Shindel AW; Dubeck F
    Rev Urol; 2016; 18(3):123-132. PubMed ID: 27833462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor fraction in cell-free DNA as a biomarker in prostate cancer.
    Choudhury AD; Werner L; Francini E; Wei XX; Ha G; Freeman SS; Rhoades J; Reed SC; Gydush G; Rotem D; Lo C; Taplin ME; Harshman LC; Zhang Z; O'Connor EP; Stover DG; Parsons HA; Getz G; Meyerson M; Love JC; Hahn WC; Adalsteinsson VA
    JCI Insight; 2018 Nov; 3(21):. PubMed ID: 30385733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA.
    Gudmundsson J; Sigurdsson JK; Stefansdottir L; Agnarsson BA; Isaksson HJ; Stefansson OA; Gudjonsson SA; Gudbjartsson DF; Masson G; Frigge ML; Stacey SN; Sulem P; Halldorsson GH; Tragante V; Holm H; Eyjolfsson GI; Sigurdardottir O; Olafsson I; Jonsson T; Jonsson E; Barkardottir RB; Hilmarsson R; Asselbergs FW; Geirsson G; Thorsteinsdottir U; Rafnar T; Thorleifsson G; Stefansson K
    Nat Commun; 2018 Nov; 9(1):4568. PubMed ID: 30410027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-derived Models Reveal Impact of the Tumor Microenvironment on Therapeutic Response.
    Shafi AA; Schiewer MJ; de Leeuw R; Dylgjeri E; McCue PA; Shah N; Gomella LG; Lallas CD; Trabulsi EJ; Centenera MM; Hickey TE; Butler LM; Raj G; Tilley WD; Cukierman E; Knudsen KE
    Eur Urol Oncol; 2018 Sep; 1(4):325-337. PubMed ID: 30467556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline variation at 8q24 and prostate cancer risk in men of European ancestry.
    Matejcic M; Saunders EJ; Dadaev T; Brook MN; Wang K; Sheng X; Olama AAA; Schumacher FR; Ingles SA; Govindasami K; Benlloch S; Berndt SI; Albanes D; Koutros S; Muir K; Stevens VL; Gapstur SM; Tangen CM; Batra J; Clements J; Gronberg H; Pashayan N; Schleutker J; Wolk A; West C; Mucci L; Kraft P; Cancel-Tassin G; Sorensen KD; Maehle L; Grindedal EM; Strom SS; Neal DE; Hamdy FC; Donovan JL; Travis RC; Hamilton RJ; Rosenstein B; Lu YJ; Giles GG; Kibel AS; Vega A; Bensen JT; Kogevinas M; Penney KL; Park JY; Stanford JL; Cybulski C; Nordestgaard BG; Brenner H; Maier C; Kim J; Teixeira MR; Neuhausen SL; De Ruyck K; Razack A; Newcomb LF; Lessel D; Kaneva R; Usmani N; Claessens F; Townsend PA; Gago-Dominguez M; Roobol MJ; Menegaux F; Khaw KT; Cannon-Albright LA; Pandha H; Thibodeau SN; Schaid DJ; ; Wiklund F; Chanock SJ; Easton DF; Eeles RA; Kote-Jarai Z; Conti DV; Haiman CA
    Nat Commun; 2018 Nov; 9(1):4616. PubMed ID: 30397198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative epigenetic taxonomy of primary prostate cancer.
    Stelloo S; Nevedomskaya E; Kim Y; Schuurman K; Valle-Encinas E; Lobo J; Krijgsman O; Peeper DS; Chang SL; Feng FY; Wessels LFA; Henrique R; Jerónimo C; Bergman AM; Zwart W
    Nat Commun; 2018 Nov; 9(1):4900. PubMed ID: 30464211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis.
    Mayrhofer M; De Laere B; Whitington T; Van Oyen P; Ghysel C; Ampe J; Ost P; Demey W; Hoekx L; Schrijvers D; Brouwers B; Lybaert W; Everaert E; De Maeseneer D; Strijbos M; Bols A; Fransis K; Oeyen S; van Dam PJ; Van den Eynden G; Rutten A; Aly M; Nordström T; Van Laere S; Rantalainen M; Rajan P; Egevad L; Ullén A; Yachnin J; Dirix L; Grönberg H; Lindberg J
    Genome Med; 2018 Nov; 10(1):85. PubMed ID: 30458854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the transcriptome of hormone-naive multifocal prostate cancer and matched lymph node metastases.
    Schmidt L; Møller M; Haldrup C; Strand SH; Vang S; Hedegaard J; Høyer S; Borre M; Ørntoft T; Sørensen KD
    Br J Cancer; 2018 Dec; 119(12):1527-1537. PubMed ID: 30449885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between genomic index lesions and mpMRI and
    Kesch C; Radtke JP; Wintsche A; Wiesenfarth M; Luttje M; Gasch C; Dieffenbacher S; Pecqueux C; Teber D; Hatiboglu G; Nyarangi-Dix J; Simpfendörfer T; Schönberg G; Dimitrakopoulou-Strauss A; Freitag M; Duensing A; Grüllich C; Jäger D; Götz M; Grabe N; Schweiger MR; Pahernik S; Perner S; Herpel E; Roth W; Wieczorek K; Maier-Hein K; Debus J; Haberkorn U; Giesel F; Galle J; Hadaschik B; Schlemmer HP; Hohenfellner M; Bonekamp D; Sültmann H; Duensing S
    Sci Rep; 2018 Nov; 8(1):16708. PubMed ID: 30420756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, Pathological and Oncologic Findings of Radical Prostatectomy with Extraprostatic Extension Diagnosed on Preoperative Prostate Biopsy.
    Faisal FA; Tosoian JJ; Han M; Macura KJ; Pavlovich CP; Lotan TL
    J Urol; 2019 May; 201(5):937-942. PubMed ID: 30414957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of bone flare on
    Weisman AJ; Harmon SA; Perk TG; Eickhoff J; Choyke PL; Kurdziel KA; Dahut WL; Humm JL; Apolo AB; Larson SM; Morris MJ; Perlman SB; Liu G; Jeraj R
    Prostate Cancer Prostatic Dis; 2019 May; 22(2):324-330. PubMed ID: 30413807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A non-canonical SWI/SNF complex is a synthetic lethal target in cancers driven by BAF complex perturbation.
    Michel BC; D'Avino AR; Cassel SH; Mashtalir N; McKenzie ZM; McBride MJ; Valencia AM; Zhou Q; Bocker M; Soares LMM; Pan J; Remillard DI; Lareau CA; Zullow HJ; Fortoul N; Gray NS; Bradner JE; Chan HM; Kadoch C
    Nat Cell Biol; 2018 Dec; 20(12):1410-1420. PubMed ID: 30397315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulated gene expression predicts tumor aggressiveness in African-American prostate cancer patients.
    Ali HEA; Lung PY; Sholl AB; Gad SA; Bustamante JJ; Ali HI; Rhim JS; Deep G; Zhang J; Abd Elmageed ZY
    Sci Rep; 2018 Nov; 8(1):16335. PubMed ID: 30397274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of recurrent prostate cancer after radiotherapy: long-term results from CALGB 9687 (Alliance), a prospective multi-institutional salvage prostatectomy series.
    Mohler JL; Halabi S; Ryan ST; Al-Daghmin A; Sokoloff MH; Steinberg GD; Sanford BL; Eastham JA; Walther PJ; Morris MJ; Small EJ
    Prostate Cancer Prostatic Dis; 2019 May; 22(2):309-316. PubMed ID: 30385835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.